Synthesis and X-ray crystallography of cholest-3,5-diene-7-one-oxime

Cholest-3,5-diene-7-one-oxime (C₂₇H₄₃NO) was prepared using a usual synthetic route and its three-dimensional structure was determined by X-ray diffraction methods. The transparent platelike crystals of this compound crystallized in the monoclinic space group P2₁, with unit cell parameters a = 14.302(2) Å, b = 11.475(2) Å, c = 15.919(4) Å, = 106.04(1)°, (Cu K) = 1.5418 Å, Z = 4. The structure was solved by direct methods and refined to an R-value of 0.075 for 4640 observed reflections. Two crystallographically independent molecules were observed in the asymmetric unit cell. The ring A in both the molecules was found to exist in 1,10 half-chair conformation while ring C in chair conformation. The rings B and D in both the molecules adopted different conformations. Three intermolecular interactions of the type C–H O and C–H N were also observed.     

Amino acid complexes of [Co(III) (trien)]+3

Seven ₂ complexes have been investigated and the structural parameters compared with literature values and molecular mechanics calculations. All ₂ compounds exhibit the (S,S,) or, (R,R,) configuration. Three of the ₂ complexes have monocoordinated amino acids or amino acid esters while the amino acid is chelated in the others. The Co–N bondtrans to the amino acid oxygen or a Cl^– varies significantly in length due to thetrans-effect. The chelate rings are twisted to minimize torsional interactions and the changes in conformation in the various structures can be modeled by molecular mechanics. In one complex the carbonyl groups of enantiomeric complexes are bridged by silver ions. In ₂[Co(trien)(C-formylglycine)]Cl₂ · H₂O the carbonyl oxygen of the chelated amino acid is protonated and the formyl group exists in the enol form.     

Structural characterization and excited-state properties of luminescent <Emphasis Type="Italic">Tris</Emphasis>-(μ -3-methyl-5- trifluoromethylpyrazolato)trigold(I)

Tris-(-(3-methyl-5-trifluoromethylpyrazolato)-N:N)triangulo-trigold(I), (3,5-tfmpz)₃ Au₃, has been synthesized and exhibits a planar nine-member ring containing a central gold triangle with an average intramolecular Au–Au distance of 3.3455(8) Å. The complex crystallizes in the monoclinic space group Cc with a = 12.998(2) Å, b = 22.910 (3) Å, c = 7.217(1) Å, and = 104.781(1). The solid-state structure consists of sheets of (3,5-tfmpz)₃Au₃ units stacked in an offset fashion along the c axis such that one gold atom in each Au₃ unit (Au1) lies approximately over the midpoint of the Au1–Au3 edge of the triangle in the layer below it. The intermolecular Au–Au distances are between 3.880(1) and 4.023(1) Å, which are too long for there to be significant intertrimer bonding interaction suggesting that any supramolecular organization may be due to hydrogen-fluorine and fluorine-fluorine interactions between the molecules. The complex exhibits excitation-dependent emission at room temperature in the solid state. The structured higher energy emission (_em = 468, 517, and 556(sh) nm) is believed to be a ligand-centered ^* transition with a lower energy unstructured emission (_em = 658 nm) assigned to the classical Au–Au excited state transition.     

Crystal structure of 17β-hydroxy-17α-methyl-5α-androstano [2,3-C] Furazan (Furazabol)

The crystal and molecular structure of 17-hydroxy-17-5-androstano [2,3-C] Furazan, Furazabol (C₂₀H₂₄N₂O₂), has been determined by direct methods and refined by full matrix least squares to a final R of 0.0528 for 1927 observed reflections and 216 parameters, CuK, = 1.54178 Å. The compound crystallizes with two molecules in the asymmetric unit, Z = 4, Dc = 1.131 Mg m^–3 space group P2₁, with unit cell parameters a = 18.747(3), b = 6.346(5), c = 15.647(4) Å, = 99.96(2)°, V = 1833.9 ų, (CuK) = 0.584 mm^–1. Whilst the two independent molecules have similar overall geometry there are small differences in bond lengths, bond angles and torsion angles in rings A and D and significant conformational differences in ring A. The A ring adopts a half-chair conformation in molecule A and an intermediate between a half-chair and a sofa in molecule B. The D ring in molecule A has a 13/14 half-chair conformation and in molecule B a conformation between an envelope and half-chair.     

Synthesis and structural characterization of CsAg5Se3 and RbAg3Te2

The syntheses and structure determinations of CsAg₅Se₃ (I) and RbAg₃Te₂ (II) are reported. Both compounds were prepared by using supercritical ethylenediamine at 300°C for 6 days reacting alkali polychalcogenides with silver. For the compound I; tetragonal space group P4₂/mnm, a = 14.083(2)Å, c = 4.410(2)Å, V = 874.5(4)ų, Z = 4, D = 6.905 Mg/m³, MoK radiation, = 0.71073, = 27.493 mm^–1, F(000) = 1568, R = 0.022, Rw = 0.026 for 472 independent reflection. For compound II; monoclinic space group C2/m, a = 17.546(2)Å, b = 4.617(2)Å, c = 9.165(2)Å, = 113.04(2)°, V = 683.31(12)ų, Z = 2, D = 6.457 Mg/m³, MoK radiation, = 0.71073, = 23.825 mm^–1, F(000) = 1128, R = 0.019, Rw = 0.027 for 690 independent reflection.     

Hydrogen-bond networks in the mono- and diprotonated cyclic diamine [9]aneN2S

The hydrogen-bond networks in the mono- and diprotonated cyclic diamine, 1-thia-4,7-diazacyclononane, [9]aneN₂S, have been examined. Crystals of the monoprotonated, form [9]aneN₂S HCl, contain a ribbon-like network of alternating strong and weak intermolecular N H Cl hydrogen bonds and weak intramolecular N H N hydrogen bonds. Crystal data for [9]aneN₂S HCl: monoclinic, a = 6.6640(6) Å, b = 10.3493(9) Å, c = 6.9807(6) Å, = 108.847(1)°, V = 455.63(7) ų, space group P2₁, Z = 2. In the di-protonated form, [9]aneN₂S 2HBr, the ribbon-like network comprises strong intermolecular and weak intramolecular N H Br hydrogen bonds. Crystal data for [9]aneN₂S 2HBr: orthorhombic, a = 12.5918(13) Å, b = 8.0753(9) Å, c = 10.6856(11) Å, V = 1086.5(2) ų, space group Pnma, Z = 4. The chloride anions of [9]aneN₂S HCl align in interlocking columns in the a- and c-direction whereas the bromide anions in [9]aneN₂S 2HBr occupy channels in the b-direction.     

Molecular structure of P-(2,4,6-tri-tert-buthylphenyl)-phenylmethylene(phenylsulfonylimino)-σ3λ5-phosphorane

The crystal and molecular structure of P-(2,4,6-tri-tert-buthylphenyl)-phenylmethylene (phenylsulfonylimino)-³⁵-phosphorane, 2,4,6-Bu^t ₃-C₆H₂-P(=CHPh)(=N--SO₂Ph), has been determined. Crystal data: triclinic, , a = 9.472(5), b = 11.427(5), c = 13.684(5) Å, = 90.61(3), = 101.21(4), = 97.02(4)°, V = 1441.1 ų, Z = 2, D _c = 1.20 g cm^–3. The observed in 1 noticeable elongation of the P=N bond 1.563(3) Å and shortening of the P=C bond 1.617(3)Å have been discussed in terms of the electron withdrawing ability of substituents on the basis of ab initio (HF/6–31+G**) calculations of the model systems.     

Crystal structure and conformation of N-(t-butoxycarbonyl)-L-isoleucyl-L-alanine benzylester

C₂₂N₂O₅H₃₂,M _r =404.5, monoclinic,C2,a=21.781(5),b=5.065(1),c=22.333(4)Å,=112.81(2)°,V=2271.1(9)ų,D _calc=1.148 g cm³, (CuK )=1.5418 Å,=5.89 cm^–1,F(000)=848, room temperature,R=0.058 for 2178 unique reflections [I2.5(I)]. The peptide linkage is in thetrans conformation. The molecule adopts the-sheet structure. The crystal structure is stabilized by a three-dimensional network of N-HO and C-HO hydrogen bonds.DCB Contribution No. 813.     

Structure of 9α, 11β-dichloro-4-pregnene-3,20-dione,C21H28O2Cl2

The crystal and molecular structure of 9, 11-dichloro-4-pregnene-3,20-dione, C₂₁H₂₈O₂C1₂, has been determined:M _r =383.4,P3₁,a=7.358(2),c=30.137(20) Å,V _c =1413(2)ų,Z=3,D _x =1.35 g cm^–3, (MoK)=0.71073Å,=3.6 cm^–1,F(000)=612,T80K,R=0.060,R _w =0.052 for 2376 unique observed reflections. The steroid skeleton exhibits a flattening of theA ring relative to the rest of the molecule caused by halogen substituents. The title compound has a very high relative binding affinity for the rabbit uterine progesterone receptor. The high binding affinity may result from the flattening of theA ring relative to the rest of the steroid skeleton.     

Crystal structures of five policyclic compounds related to the natural product forskolin

(3(Z),4,6a,9a,9b)-(±)-3a,4,6a,7,8,9,9a,9b-octahydro-4,7,7, 9b-tetramethyl-3a-[3-(methoxymethyloxy)-3-methyl-1-butenyl]-5H-naphto[1,8-de]-1,3-dioxin-6-one (I), C₂₂H₃₆O₅,M _r=378.51, monoclinic,P2₁/n,a=6.330(1),b=14.576(2),c=22.837(2)Å,=93.04(1)°,V=2104.1(2)ų,Z=4,D _c=1.19 Mg/m³, (MoK)=0.71069Å,=0.8 cm^–1,F(000)=832,T=298 K,R=0.054 for 1971 observed reflections; (7a,10a,10b,12)-(±)-7a,9, 10,10a,10b,11,12,12a-octahydro-2,2,10,10,10b,12a-hexamethyl-2H,8H-1-benzopyrano[4a,5,6,-de][1,3,2]-benzodioxin-11-one (II), C₂₀H₂₉O₄,M _r=334.5, triclinic,P-1,a=10.595(2),b=12.152(1),c=8.073(1)Å,=106.53(1),=105.65(1), =66.29(1)°,V=897.9(2)ų,Z=2,D _c=1.24 Mg/m³, (MoK)=0.71069Å,=0.8 cm^–1,F(000)=362,T=298 K,R=0.046 for 2848 observed reflections; (7a,10a,10b,12, 12a)-(±)-7a,9,10,10a,10b,11,12,12a-octahydro-2,2,10,10,10b,12a-hexamethyl-2H,8H-1-benzopyrano[4a,5,6-de][1,3,2]-benzodioxin-11, 12-diol (III), C₂₀H₃₂O₅ (two molecules in the asymmetric unit),M _r=352.2, triclinic,P-1,a=12.948(3),b=13.615(3),c=12.197(4)Å,=101.16(2),=111.88(2), =69.48(2)°,V=1863.8(9)ų,Z=2,D _C=1.26 Mg/m³,(MoK)=0.71069 Å,=0.8 cm^–1,F(000)=768,T=298 K,R=0.060 for 4570 observed reflections; 4-acetoxy-4-[[(4a,5,8a)-(±)-hexahydro-4a,6,6-trimethyl-4H-1,3-benzodioxin-4-one]-5-yl]butan-2-one (IV), C₁₇H₂₆O₆,M _r=326.4, monoclinic,P2₁/c,a=10.495(2),b=12.050(2),c=14.216(2)Å,=108.51(1)°,V=1704.8(5)ų,Z=4,D _c=1.27 Mg/m³,(MoK)=0.71069 Å,=0.9 cm^–1,F(000)=704,T=298 K,R=0.049 for2455 observed reflections; (3a,4,5,6,6a,9a,9b)-(±)-4,5-epoxy-decahydro-3, 3a-dihydroxy-2-ethoxy-4,7,7,9b-tetramethyl-naphto-[1,8-bc]-pyran-6-ol-acetate (V), C₂₀H₃₂O₇,M _r=383.5, monoclinic,C2/c,a=10.353(2),b=17.975(3),c=21.188(3)Å,=91.29(1)°,V=3942(1)ų,Z=8,D _c=1.29 Mg/m³,(MoK)=0.71069 Å,=0.8 cm^–1,F(000)=1664,T=298 K,R=0.051 for 2120 observed reflections. We report here the complete structures of four decalin derivatives (compoundsI, II, III, V) and one related compound (compoundIV) synthetized in order to find an efficient synthetic approach for the natural productforskolin.     

Electronic spectra of 2-chloropicolines,their N-oxides,and 2-chloro-4-nitropicoline N-oxides

UV spectra of 2-chloropicolines, their N-oxides and 2-chloro-4-nitropicoline N-oxides are presented and the influence of substituents on the _raax and _max of spectral bands are discussed. The electronic spectra were calculated by a modified INDO method. Transition energies, intensities and assignments were compared with UV spectra. The latter were recorded for the first time on all the title compounds.     

Molecular structure of 1-phenyl-1-dimethylamino-4,4-bis(trimethylsilyl)-2-aza-3λ3-phosphabutadiene-1,3

The crystal and molecular structure of 1-phenyl-1-dimethylamino-4,4-bis(trimethylsilyl)-2-aza-3³-phosphabutadiene-1,3, Me₂N(Ph)C=N—P=C(SiMe₃)₂ (1), has been determined. Crystal data: triclinic, P1¯, a = 8.975(4), b = 10.001(5), c = 12.440(6) Å, = 79.04(4), = 77.98(4), = 73.07(4)°, V = 1034.7 ų, Z = 2, and D _c = 1.08 g cm^–3. The main geometrical parameters of 1 as well as ab initio (HF/6-31+G**) calculations of the model systems show no clear evidence of high efficiency of the (C=N)— (P=C) conjugation.     

Synthesis and structural characterization of 2,6-bis-(N-methylenemorpholino)-4-ter-butylphenol

The crystal and molecular structure of the title compound, C₂₀H₃₂N₂O₃, has been determined from X-ray diffraction data using CuK radiation (=1.5418 Å). The compound crystallizes in triclinic space groupP1^¯ with a=8.828(1),b=18.680(1),c=6.272(2)Å, =93.42(1), =0.24(2), =77.93(1)°,V=1009.4(2)ų, andZ=2. The structure was solved by direct methods and the full-matrix least-squares refinement leads the finalR-factor to 0.065 for 3481 observed reflections withI3(I). The phenyl ring is planar and the morpholino rings assume perfect chair conformation. The molecules are held together by van der Waals forces.DCB Contribution No. 810.     

Crystal structure of 1,5-dibromonaphthalene and of disordered 1,8-dibromonaphthalene

The crystal structure of 1,5-dibromonaphthalene, C₁₀H₆Br₂, has been determined from a single crystal x-ray study. The compound crystallizes in the monoclinic space groupC2/c with four molecules per unit cella=14.576(5),b=4.049(1),c=15.046(6) Å, and=92.18(3)°. The structure was solved by the execution of the programDirdif in space groupP1. Full-matrix least-squares refinement (inC2/c) using 544 reflections with sin/<0.594 and F ₀>6(F ₀) converged withR=0.039 andR _w =0.050. The results of an X-ray study of 1,8-dibromonaphthalene (P2₁/c, a=8.050(4),b=10.898(5),c=11.083(5) Å,=107.83(4)°; disordered;R=0.11) are included as an appendix.     

Crystal structure of tylophorine methiodide monohydrate,C25H30NO 4 + I−·H2O

The crystal structure of tylophorine (Chemical name 2,3,6,7 tetramethoxy phenanthro [9,10:6, 7] indolizidine. Contribution No. 0871.) methiodide monohydrate has been determined. C₂₅H₃₀NO ₄ ⁺ I^–·H₂0, triclinic, P,a=8.831(1)Å, b=10.842(2),c=13.902(2), =105.0(1)^o, =104.7(1), =97.3(1),V=1210.22ų, Z=2,D _x =1.428 g./cm^–3, (CuK)=1.54184Å, (CUK)=107.2 cm^–1, F(000)=544,T=295^oK,R=0.038,Rw=0.046, for 2331 observed reflections withI2(I). Apart from van der Waals forces, the structure is stabilized by two hydrogen bonds of the type Ow(H) ... O and Ow(H) ... I^– involving the water molecule as the donor and atom O4 of the methoxy group and I^– as acceptors.     

Crystal and molecular structure of 5-ethoxy-4-methylene-exo-10-oxatricyclo[5.2.1.02,6]-deca-8-ene-3-ol,C12H16O3

The structure of the title compound, C₁₂H₁₆O₃, was determined by X-rays.M _r =208.26, triclinic, space groupP¯1,a=7.802(2),b=8.449(2),c=9.069(1) Å,=90.79(1)°,=105.57(1)°, =106.07(1)°,Z=2,D _x =1.26 Mg m^–3; MoK radiation (graphite crystal monochromator, =0.71069 Å),(MoK)=0.96 cm^–1,T=290 K. Final conventionalR-factor=0.046,R _w =0.067 for 3009 observed reflections and 184 variables. The structure was solved using Patterson methods andDirdif, and the resulting all cis-endo configuration of the alcohol group on C(3) and the ethoxy group on C(5) shows that the stereochemistry of the metal-mediated addition reaction involved is solely determined by steric factors.     

Crystal structure of a synthetic anabolic agent: stanazolol ethanol solvate, 17β-hydroxy-17α methylandrostano[3,2-c]pyrazole ethanoate

The crystal and molecular structure of 17-hydroxy-17 methylandrostano[3,2-c]pyrazole ethanoate (stanazolol ethanol solvate), C₂H₃₀N₂OC₂H₅OH, has been determined by direct methods and refined by full-matrix least squares to a final R of 0.0577 for 4021 observed reflections and 245 parameters using Cu K radiation, = 1.54178 Å. The compound crystallizes in space group P2₁2₁2₁ with Z = 4 molecules per unit cell. In the steroid skeleton the ring A adopts a half-chair conformation, being considerably strained, as a consequence of the fused planar pyrazole ring E. Rings B and C however are chairs and ring D has a 13,14 half-chair conformation. All rings of the steroid skeleton are trans-connected. The OH group of the solvated ethanol molecule is hydrogen bonded to the -oriented carbonyl substituent O(20) of ring D. The molecules are further held together in the crystal structure by head–tail hydrogen bonding between N(1)H in the pyrazole ring and O(20), which consequently is an acceptor for the two H-bonds. Overall the molecule lacks any significant curvature with no interplanar dihedral angle greater than 7°. Possible binding modes of stanazolol with the human androgen receptor are discussed.     

Crystal structure of 14, α-hydroxy,sandarocopimar-7, 15-diene-19-oic acid

C₂₀H₃₀O₃, M _r =318.46, Monoclinic,P2₁,a=12.232(2) ,b=11.491(2) ,c=14.160(3) , =115.2°(3),V=1800.3(7) ³,Z=4,D _x =1.18 Mg m^–3, (CuK)=1.5418 , =5.3 cm^–1,F(000)=696,T=298 K. FinalR=0.044 for 2645 reflections withI>2. The two crystallographically independent molecules in the unit cell adopt essentially similar conformations. The structure reveals atrans relationship between the hydrogen at C(9) and the methyl group at C(20). The stereochemistry at C(13) is S. Apart from van der Waals forces the structure is stabilized by hydrogen bonds.     

Crystal and molecular structure of 3-methoxy-6-nor-6,7-secooestra-1,3,5(10),9(11), 14-penten-17-one-8β-ethyl carboxylate

C₂₀H₂₂O₄,M _r =326.39, triclinic,P¯1,a=10.365(2),b=11.383(2),c=8.461(1) Å, =103.60(1),=104.44(1), =105.23(1)°,Z=2, (CuK)=1.54178 Å;R=0.0633 for 1940 reflections. The results of the X-ray analysis have shown that the ethyl carboxylate substituent is oriented. The geometry of the main skeleton of the molecule has not revealed any significant differences in the present compound and in the case of the epimeric molecule.     

The structure of 20 oximo-5α-pregnano-16-eno[3,4-C]-1′,2′,5′-oxadiazole (HS976)

The crystal and the molecular structure of the steroidal oxadiazole 20-oximo-5-pregnano-16-eno[3,4-C]-1,2,5-oxadiazole (C₂₁H₂₈N₂O₃) has been determined by direct methods, and refined to a finalR of 0.086 for 3100 observed reflections. The compound crystallizes in space groupP2₁, with cell dimensionsa=18.284(6),b=13.992(4),c=7.370(3)Å,=96.97(3)°;V=1885 ų,Z=4,D _x =1.27 g cm^–3, =1.5418 Å, (CuK =5.95 cm^–1. The two independent molecules are related by a pseudo twofold axis. Both molecules exhibit similar overall topography, rings A, B, C, and D adopting distorted sofa, chair, chair, and distorted envelope conformations, respectively.